Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Nettersheim

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|March 3, 2025
Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistanceMara Kotthoff, Margaretha A Skowron, Felix Bremmer, et al.
Biology of Reproduction|September 25, 2009
Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenanceSusanne Weber, Dawid Eckert, Daniel Nettersheim, et al.
Experimental Hematology & Oncology|November 24, 2023
Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugatesGamal A Wakileh, Philipp Bierholz, Mara Kotthoff, et al.
Neoplasia (New York, N.Y.)|June 21, 2021
On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitroCornelia Fink, Nelli Baal, Jochen Wilhelm, et al.
Journal of Cellular and Molecular Medicine|January 15, 2021
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumoursWasco Wruck, Felix Bremmer, Mara Kotthoff, et al.
Molecular Medicine (Cambridge, Mass.)|March 29, 2023
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic optionsMargaretha A Skowron, Mara Kotthoff, Felix Bremmer, et al.
Experimental Cell Research|May 4, 2024
Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignanciesMelanie R Müller, Aaron Burmeister, Margaretha A Skowron, et al.
Cancers|April 11, 2020
<i>ARID1A</i> Regulates Transcription and the Epigenetic Landscape via POLE and DMAP1 while <i>ARID1A</i> Deficiency or Pharmacological Inhibition Sensitizes Germ Cell Tumor Cells to ATR InhibitionLukas Kurz, Alissa Miklyaeva, Margaretha A Skowron, et al.
Histopathology|September 24, 2020
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reactionAlexander Fichtner, Annika Richter, Simon Filmar, et al.
British Journal of Cancer|September 19, 2023
Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targetsFelix Bremmer, Pailin Pongratanakul, Margaretha Skowron, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|March 3, 2025
Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistanceMara Kotthoff, Margaretha A Skowron, Felix Bremmer, et al.
Biology of Reproduction|September 25, 2009
Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenanceSusanne Weber, Dawid Eckert, Daniel Nettersheim, et al.
Experimental Hematology & Oncology|November 24, 2023
Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugatesGamal A Wakileh, Philipp Bierholz, Mara Kotthoff, et al.
Neoplasia (New York, N.Y.)|June 21, 2021
On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitroCornelia Fink, Nelli Baal, Jochen Wilhelm, et al.
Journal of Cellular and Molecular Medicine|January 15, 2021
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumoursWasco Wruck, Felix Bremmer, Mara Kotthoff, et al.
Molecular Medicine (Cambridge, Mass.)|March 29, 2023
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic optionsMargaretha A Skowron, Mara Kotthoff, Felix Bremmer, et al.
Experimental Cell Research|May 4, 2024
Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignanciesMelanie R Müller, Aaron Burmeister, Margaretha A Skowron, et al.
Cancers|April 11, 2020
<i>ARID1A</i> Regulates Transcription and the Epigenetic Landscape via POLE and DMAP1 while <i>ARID1A</i> Deficiency or Pharmacological Inhibition Sensitizes Germ Cell Tumor Cells to ATR InhibitionLukas Kurz, Alissa Miklyaeva, Margaretha A Skowron, et al.
Histopathology|September 24, 2020
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reactionAlexander Fichtner, Annika Richter, Simon Filmar, et al.
British Journal of Cancer|September 19, 2023
Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targetsFelix Bremmer, Pailin Pongratanakul, Margaretha Skowron, et al.
Pageof 8